Article
CD34 expression on bone marrow blasts is a novel predictor of poor prognosis independent of FlT3-ITD in acute myeloid leukemia with the NPM1-mutation.
Leukemia research - 1 Jun 2013
Zhu Hong-Hu, Liu Yan-Rong, Jiang Hao, Lu Jin, Qin Ya-Zhen, Jiang Qian, Bao Li, Ruan Guo-Rui, Jiang Bin, Huang Xiaojun
Abstract excerpt
To explore the prognostic value of CD34 expression in NPM1-mutated acute myeloid leukemia (NPM1m+AML), seventy-one NPM1m+AML patients were retrospectively analyzed. The patients with >7% CD34 expression (according to the ROC analysis) had a lower complete remission (CR) rate after 1 course of induction, disease-free survival (DFS), and overall survival (OS) compared to those with ≤7% CD34 expression (p=0.0038;...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
